UBS Initiates Coverage On Kardigan with Buy Rating, Announces Price Target of $25
10/12/2026
Impact: 75
Healthcare
UBS analyst Alice Nettleton has initiated coverage on Kardigan (NASDAQ: KARD) with a Buy rating. The firm has set a price target of $25 for the stock.
AI summary, not financial advice
Share: